Global Packaging and Labeling CDMO Market is expected to grow at a healthy rate of 9 to 10% by 2027 - Aphena, Eurofins Scientific, Catalent, PCI Pharma, Pfizer, Jabil, Tecomet, Integer

Contract Development and Manufacturing Organizations (CDMOs) specializing in packaging encompass a wide range of services, which include product development, clinical and commercial API production, the manufacturing of medication products, primary and secondary packaging, labeling, sterilization, and distribution. They also offer customized packaging solutions to manufacturers for some complex or specific products.

Demand for Environment Friendly Packaging and Labeling, and Compliance with Regulatory Requirements are the Key Factors Triggering the Growth of the Packaging and Labeling CDMO Market

The global packaging and labeling CDMO market is a rapidly growing market. In recent years, CDMOs have experienced significant transformations in their packaging and labeling practices, reflecting a multifaceted evolution within the market. Primarily, sustainability has emerged as a dominant factor, with an emphasis on environmentally friendly packaging and labeling solutions.

For instance,

In January 2021, Jabil Inc. has revealed its acquisition of Ecologic Brands, Inc., a prominent sustainable packaging company. This strategic move represents a substantial enhancement to Jabil's sustainable packaging portfolio.

Furthermore, in markets such as pharmaceuticals and healthcare, stringent regulations have increased the demand for serialization and track-and-trace solutions. CDMOs are incorporating advanced technologies like QR codes, RFID, etc. to ensure adherence to regulatory requirements, enhance transparency within the supply chain, and combat counterfeiting. Security features, such as tamper-evident seals and holograms, are gaining prominence due to rising concerns surrounding product tampering and counterfeiting.

Major Factors Driving the Growth of the Global Packaging and Labeling CDMO Market

The global packaging and labeling CDMO market is projected to witness a healthy growth rate over the forecast period. Filling and packaging play an important role in the overall contract manufacturing process. The requirement for a specialty packaging service has given surge to an alternate industry of contract manufacturing. Most companies are now outsourcing the packaging task to companies who are skilled in handling the packaging of drugs and devices.

Rising geriatric population, stringent regulatory requirements of governing agencies, and advanced packaging technologies are some of the factors that will boost the growth of the global packaging and labeling CDMO market across the world. In addition, the lack of in-house packaging capabilities, expertise, and budget constraints for small companies is also expected to accelerate the global market's growth.

For instance,

In June 2023, Catalent announced that its OneBio® Suite, an integrated solution encompassing development, manufacturing, and supply, has been expanded to encompass various biologic modalities. This suite provides customers with an all-inclusive service designed to expedite the progression of programs from development to manufacturing. This includes activities such as fill/finish, packaging, and assistance with clinical supply and commercial launch.

North America Accounts for the Largest Share in the Global Packaging and Labeling CDMO Market

North America is expected to continue to dominate the global packaging and labeling CDMO market in the upcoming years. This can be mainly attributed to the rising elderly population, robust R&D activities, and the presence of key players in the region. However, the Asia-Pacific region is expected to witness the highest CAGR in the forecast period. Other factors such as technological advancements in the field of packaging and rising investments in the healthcare sector are driving the Asia-Pacific market.

Competitive Landscape Analysis: Packaging and Labeling CDMO Market

Some of the key and established players operating in the global packaging and labeling CDMO market are Aphena Pharma Solutions, Eurofins Scientific, Catalent, PCI Pharma, Pfizer CentreOne, Becton, Dickinson & Co, Almac Group, Jabil, Tecomet, Integer.

Organic and Inorganic Growth Strategies Adopted by the Leading Market Players to Establish Their Foothold in the Packaging and Labeling CDMO Market

All leading players operating in this global market are adopting both organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to garner a larger market share.

For instance,

In March 2022, Almac Pharma Services introduced its distinctive Ultra-Low Temperature Solutions of commercial packaging, labeling, and distribution services, in order to facilitate the introduction of Advanced Therapy Medicinal Products (ATMPs) from its European Centre of Excellence. Almac customized services for Just-in-Time labeling, packaging, and serialization under ultra-low temperatures (ranging from -20°C to -80°C) will provide clients with an exclusively tailored experience, ensuring that each facet of this intricately detailed process is finely adjusted to meet the precise needs of both the client and their valuable product.

The global packaging and labeling CDMO market is a growing market and is expected to gain a further momentum in the upcoming years due to a strong emphasis on developing new drugs and devices, growing investments in the R&D activities to introduce several advanced products, and aggressive organic and inorganic growth strategies followed by the leading market players.

Explore Detailed Insights on Packaging and Labeling CDMO Market @ https://meditechinsights.com/packaging-and-labeling-cdmo-market/

Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
https://meditechinsights.com/

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

This release was published on openPR.